Reduction in serum levels of antimitochondrial (M2) antibodies following immunoglobulin therapy in severe combined immunodeficient (SCID) mice reconstituted with lymphocytes from patients with primary biliary cirrhosis (PBC)

Clinical and Experimental Immunology

Volumn 105, Issue 2, 1996, Pages 266-273

  Abedi, M R ^a   Hammarstrom L ^a,b   Broome U ^a   Angelin, B ^a   Smith, C I Edvard ^a,b   Christensson, B ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antimitochondrial antibodies; Autoimmune disease; Immunoglobulin therapy; Primary biliary cirrhosis; SCID mice

Indexed keywords

ALPHA 2 MACROGLOBULIN; AUTOANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MITOCHONDRION ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CASE REPORT; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0030018533     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-767.x     Document Type: Article

References (44)

1. Dickson ER, Fleming DR, Ludwig J. Primary biliary cirrhosis. Prog Liver Dis 1979; 6:487-502.
2. Kaplan MM, Primary biliary cirrhosis. N Eng J Med 1987; 316:521-8.
3. Portmann B, Popper H, Neuherger J, Williams R. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology 1985; 88:1777-90.
4. Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study. Gastroenterology 1990; 98:1567-71.
5. Nyberg A, Loof L. Primary biliary cirrhosis: clinical features and outcome with special reference to asymptomatic disease. Scand J Gastroenterol 1989; 24:57-64.
6. Roll J, Boyer JL, Klatskin G. The prognostic importance of clinical and histological features in asymptomatic and symptomatic primary biliary cirrhosis. N Eng J Med 1983; 308:1-7.
7. James SP, Hoofnagle JH, Strober W, Jones EA. Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med 1983; 99:500-12.
8. Berg PA, Klein R, Linderborn-Fotinos J, Klöppel W. ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet 1982; ii:1423-5.
9. Lindenborn-Fotinos J, Baum H, Berg PA. Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen. Hepatology 1985; 5:763-9.
10. Bosma GC, Custer RP, Bosma MJ. A severe immunodeficiency mutation in the mouse. Nature (Lond.) 1983; 301:527-30.
11. Schuler W, Weiler IJ, Schuler A et al. Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency. Cell 1986; 46:963-72.
12. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988: 241:1632-9.
13. Kamel-Reid S, Dick JE. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 1988; 242:1706-9.
14. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature (Lond.) 1988; 335:256-9.
15. Mosier DE, Gulizia RJ, Baird SM et al. Studies of HIV infection and the development of Epstein Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr Top Microbiol Immunol 1989; 152:195-9.
16. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 1992; 255:1137-41.
17. Barry TS, Haynes BF. In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice. J Clin Immunol 1992; 12:311-24.
18. Saxon A, Macy E, Denis K, Tary LM, Witte O, Braun J. Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J Clin Invest 1991; 87:658-65.
19. Smith CIE, Abedi MR. Islam KB, Johansson ME, Christensson B, Hammarstrm L. Humoral immunity in scid mice reconstituted with cells from immunoglobulin-deticient or normal humans. Immunol Rev 1991; 124:113-38.
20. Krams SM, Dorshkind K, Gershwin ME. Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med 1989; 170:1919-30.
21. Hammarstršm L, Lundkvist I, Petterson A, Smith CIE. The use of IVIG in inimunological disorders other than cytopenia. In: Yap PL, ed. Clinical application of intravenous immunoglobulin therapy. New York: Churchill Livingstone Inc., 1992:117-37.
22. Bussel JB, Kimberly RP, Inman RD. Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood 1983; 62:480-6.
23. Cross AS. The use of intravenous immunoglobulin in bacterial infections. In: Yap PL, ed. Clinical application of intravenous immunoglobulin therapy. New York: Churchill Livingstone Inc., 1992:139-66.
24. Griffiths JK, Snydman DR. The use of intravenous immunoglobulin in viral infections. In: Yap PL, ed. Clinical application of intravenous immunoglobulin therapy. New York: Churchill Livingstone Inc., 1992:167-201.
25. Duchosal MA, McConahey PJ, Robinson CA, Dixon FJ. Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med 1990; 172:985-8.
26. Tighe H, Silverman GJ, Kozin F et al. Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur J Immunol 1990; 20:1843-8.
27. Macht L, Fukuma N, Leader K et al. Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol 1991; 84:34-42.
28. Martino G. DuPont BL, Wollmann RL, Bongioanni P, Anastasi J, Quintans J, Arnason BG, Grimaldi LM. The human-severe combined immunodeficiency myasthenic mouse model: a new approach for the study of myusthenia gravis. Ann Neurol 1993; 34:48-56.
29. Abedi MR, Hammarström L, Christensson B, Smith CIE. Human humoral immunity in SCID mice. In: Roncarolo MG, Péault B, Namikawa R, eds. Human hematopoiesis in SCID mice. Austin: R.G. Landes Co., 1995:71-103.
30. Cannon MJ, Pisa P, Fox RI, Cooper NR. Epstein Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice. J Clin Invest 1990; 85:1333-7.
31. Williams PE, Todd AAM, Yap PL. IVIG therapy in primary and secondary immunodeficiency. In: Yap PL, ed. Clinical application of intravenous immunoglobulin therapy. New York: Churchill Livingstone Inc., 1992:63-92.
32. Schwartz SA. Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disrders. J Clin Immunol 1990; 10:81-89.
33. Ronda N, Hurez V, Kazatchkine MD. Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory disease. Vox Sang 1993; 64:65-72.
34. Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE. Antiidiotypic suppression of autoantibodies to factor VIII (anti-haemophilic factor) by high dose intravenous immunoglobulin. Lancet 1984; ii:765-8.
35. Cook L, Howard JF, Folds JD. Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis. J Clin Immunol 1988; 8:23-31.
36. Klaesson S, Ringdén O. Markling L, Remberger M, Lundkvist I. Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro. Scand J Immunol 1993; 38:477-84.
37. Abedi MR, Christensson B, Islam KB, Hammarstrm L, Smith CIE. Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Eur J Immunol 1992; 22:823-8.
38. Dietrich G, Kaveri SV, Kazatchkine MD. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 1992; 62:S73-S81.
39. Waldman TA, Strober W. Metabolism of immunoglobulins. Prog Allergy 1969; 13:1-110.
40. Shumack KH, Rock GA. Therapeutic plasma exchange. N Eng J Med 1984; 310:762-71.
41. Gajdos PH, Outin HD, Morel E, Raphael JC, Goulon M. High-dose intravenous gammaglobulin for myasthenia gravis: an alternative to plasma exchange? Ann NY Acad Sci 1987; 505:842-4.
42. Arsura EL, Bick A, Brunner NG, Grobe D. Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis. Am J Med Sci 1988; 295:438-43.
43. Haagsma EB, Manns M, Klein R et al. Studies of antimitochondrial antibodies in primary biliary cirrhosis before and after orthotopic liver transplantation. Hepatology 1987; 7:129-33.
44. Neuberger J, Portmann B, MacDougall BRD. Calne RY, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. New Eng J Med 1982; 306:1-4.